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Abstract. Total intravenous anesthesia and the new
parameter for administering the most recent drugs, target-
controlled infusion, as well as the introduction of new short
half-life molecules that do not accumulate have made
anesthesia in day surgery safer. In this study, the use of
auditory-evoked potentials monitoring made it possible to
determine the target plasma concentration of propofol that
induces a narcosis suﬃciently deep and strictly necessary
for eﬀectiveness, thus minimizing the anesthesiologic risk
linked to the use and the dosing of the drug, reducing the
hospitalization time, and decreasing the side eﬀects for
patients undergoing day surgery mammoplasty.
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Total intravenous anesthesia
Total intravenous anesthesia has been used success-
fully in many surgical branches because of the re-
cently introduced new short half-life molecules with
no accumulation eﬀects [7]. Furthermore, the new
parameters for administration of the most recent
drugs, target-controlled infusion, have made day
surgery operations with the patient under anesthesia
safer [2,5,8].
The aim of this study was to verify, through
monitoring of auditory-evoked potentials (AEP)
[4,5], the propofol plasma concentration target
capable of inducing a level of narcosis suﬃciently
deep and strictly necessary for eﬀectiveness, thus
minimizing the anesthesiologic risk linked to the use
and the dosing of the drug while reducing hospital-
ization time and side eﬀects [4,9].
Auditory-evoked potentials (AEP) use auditory
stimuli to evaluate the level of cerebral activity. They
have been used both in studies on learning and
memory processes and in research on the evaluation
of the anesthesia level.
To evaluate the depth of anesthesia, midlatency
AEP (MLAEP) recorded 10 to 100 min after auditory
stimulation has been primarily used because it has
shown limited intra- and interindividual variability.
The AEP A-line monitor generates an index derived
from the analysis of MLAEP waveforms. Once this
monitor has acquired the baseline signal, thanks to
sophisticated ﬁltering systems, it can extract in a
short time (only 6s) the MLAEP signal, whose
changes during anesthesia are represented by an in-
dex, the A-line ARX Index (scale of 0 to 100), which
reﬂects the hypnotic state of the individual.
The aim of this study was to control, by means of
the aforementioned monitoring, the propofol plasma
concentration suﬃcient to provoke a narcosis status
for each individual patient, avoiding the risk of
awareness and reducing side eﬀects (caused by use-
lessly high drug doses) and hospitalization time. All
this becomes even more important in plastic cosmetic
surgery, in which day surgery and short convales-
cence times are particularly signiﬁcant, because pos-
tanesthesia recovery and anesthetic metabolism may
become limiting factors.
Materials and Methods
After written informed consent, 42 American Society
of Anesthesiology (ASA) classes 1 and 2 patients
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(average age, 32 ± 4 years; average body weight,
62 ± 7 kg) who had undergone augmentation
mammoplasty with submuscular implantation of
mammary prosthesis (8 patients) and reductive
mammoplasty due to gigantomastia of medium
gravity were studied. The average length of surgery
was 72 ± 4 min for augmentation mammoplasty and
158 ± 23 min for reduction mammoplasty.
Patients with allergies or intolerances to even one
of the drugs included in this study were excluded.
According to the waiting list position, the patients
were divided into two groups of 21 each: group A and
group B. The two groups were homogeneous for age,
weight, ASA class, and type of operation.
The following anesthesiologic protocol was used
for all the patients:
 Premedication about 45 min before surgery with
intramuscular (IM) atropine 0.01 mg/kg and
intravenous (IV) midazolam 0.07 mg/kg
 Induction with a remifentanil (50 lg/ml) dose of
0.25 lg/kg/min IV
 Maintenance with air and O2, a remifentanil
(50 lg/ml) dose of 0.25 lg/kg/min IV, and cis-
atracurium (boli) 0.04 mg/kg IV at 25% of train
of four (TOF). The propofol was administered
with a target of 4 lg/ml for the group A patients
and a target of AEP values at 20 or less for the
group B patients (Table 1).
The anesthesiologic protocol is shown in Table 1. In-
traoperative monitoring involved the following: sys-
tolic pressure (SAP), dyastolic pressure (DAP), mean
arterial pressure, electrocardiogram in derivation II (II
der.), cardiac frequency (CF), oxygen saturation, end-
tidal carbon dioxide, temperature corporeal (CT),
hourly diuresis. The narcosis level of the group B pa-
tients was measured through the evaluation of AEP
(ALARIS AEP monitor, ALARIS, Florence, Italy).
Neuromuscular monitoring was performed by the
TOF watch. [3,6].
After the interruption of propofol administration, at
the end of the operation, the following parameters
were examined: spontaneous respiration, extubation
time, eye-opening time, performance of simple orders,
time of discharge from the recovery room, and pres-
ence of postoperative nausea, vomiting, shivering [1,6].
Students t-test was used for statistical analysis. All
p values less than 0.05 were considered signiﬁcant.
Data are expressed as means ± standard deviation.
Results
Good hemodynamic stability was achieved for all the
patients. Table 2 presents the examined parameters
and Table 3. presents the side eﬀects. No episodes of
awareness were reported by the patients in the post-
operative period. The plasma concentration target of
propofol in group B was 2.4 to 2.9 lg /ml.
Table 1. Anesthesiologic protocol
Group A Group B
Premedication Atropina 0.01 mg/kg IM
Midazolam 0.07 mg/kg IM
Atropina 0.01 mg/kg IM
Midazolam 0.07 mg/kg IM
Induction Remifentanil (50 /ml) Remifentanil (50 /ml)
0.25 lg/kg/min IV 0.25 lg/kg/min IV
Propofol (target 4 lg /ml) Propofol (target 4 lg /ml)
Cis-atracurium 0.20 mg/kg IV Cis-atracurium 0.20 mg/kg IV
O2-Air O2-Air
Remifentanil (50 lg /ml) Remifentanil (50 lg /ml)
0.25 lg /kg/min IV 0.25 lg /kg/min IV
Cis-atracurium (boli) 0.04 mg/kg IV,
at 25% of the TOF
Cis-atracurium (boli) 0.04 mg/kg IV,
at 25% of the TOF
Propofol Propofol
Target 4 lg /ml Target = value £ 20 AEP
IM, intramuscular; IV, intravenous; TOF, ; AEP, auditory-evoked potentials.
Table 2. Examined parameters
Group A
(min)a
Group B
(min)
Spontaneous respiration 9 ± 2 4 ± 1
Extubation 13 ± 2 6 ± 1
Eye opening time 15 ± 1 7 ± 2
Carrying out simple commands 16 ± 2 9 ± 1
ap < 0.05.
Table 3. Side effects
Group A
Patients (%)
Group B
Patients (%)
Nausea 5 (24) 2 (9)
Vomiting 3 (14) 2 (9)
Shivering 2 (9) 2 (9)
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Conclusions
The monitoring of AEPs to assess the level of narcosis
enabled achievement of the expected objectives: signif-
icantlymore rapidawakening than in the control group,
earlier discharge, and the reduction of propofol dosing,
tailor made according to individual characteristics.
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